Page 5 - Shattuck Labs News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Shattuck Labs Announces Oral Presentation of Preclinical Data at the American Association for Cancer Research (AACR) Annual Meeting 2024

Shattuck Labs Announces Oral Presentation of Preclinical Data at the American Association for Cancer Research (AACR) Annual Meeting 2024
businessinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businessinsider.com Daily Mail and Mail on Sunday newspapers.

San diegoUnited statesSan diego convention centerNorth carolinaTaylor schreiberConor richardsonGeorge frommShattuck labs incExchange commissionCancer cellChief executive officerDysregulated interferon responsivenessChief scientific officerDrug discoveryNew therapiesPresentation number

Shattuck Labs Announces Participation in Upcoming 23rd Annual Needham Virtual Healthcare Conference

AUSTIN, TX & DURHAM, NC, April 01, 2024 Shattuck Labs, Inc. , a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic.

United statesNorth carolinaGil blumTaylor schreiberConor richardsonShattuck labs incAnnual needham virtual healthcare conferenceChief executiveShattuck labsAgonist redirected checkpointMedia contact

Stephen Stout Sells 16,004 Shares of Shattuck Labs, Inc (NASDAQ:STTK) Stock

Stephen Stout Sells 16,004 Shares of Shattuck Labs, Inc (NASDAQ:STTK) Stock
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesBalyasny asset managementShattuck labs company profileShattuck labs incNeedham companyAcadian asset managementSquarepoint opsTower research capitalShattuck labsGet free reportStephen stoutAsset managementResearch capitalShattuck labs daily

Shattuck Labs Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Business Highlights

- Announced positive topline data from the ongoing Phase 1A/B clinical trial of SL-172154 in combination with azacitidine (AZA) in frontline Highe.

United statesNorth carolinaConor richardsonMirvetuximab soravtansineTaylor schreiberAmerican society of hematologyExchange commissionShattuck labs incCancer researchOno pharmaceutical co ltdHealth care conference bostonDevelopment rd expensesRna work in cancer researchHigher risk myelodysplastic syndromesAcute myeloid leukemiaAmerican society

Shattuck Labs Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Business Highlights

- Announced positive topline data from the ongoing Phase 1A/B clinical trial of SL-172154 in combination with azacitidine in frontline Higher-Risk Myelodysplastic Syndromes and frontline TP53 mutant.

United statesNorth carolinaTaylor schreiberConor richardsonMirvetuximab soravtansineCancer researchRna work in cancer researchShattuck labs incOno pharmaceutical co ltdExchange commissionDevelopment rd expensesHealth care conference bostonAmerican society of hematologyHigher risk myelodysplastic syndromesAcute myeloid leukemiaAmerican society